Your cart is empty
Legal cannabinoids in France: your comprehensive guide for 2024
CBG9, THCP, THCJD, H4CBD, HHCP and HHCPO are now banned in France. Discover Californian CBD as an alternative!
Key points:
- Many cannabinoids are legal. This includes CBD, CBG, CBN, CBDV, CBDP, THCV, THCP, THCJD, H4CBD and Magic Sauce.
- To be legal, cannabinoid products must contain less than 0.2% THC.
France, like many countries, has evolved in its regulation of cannabinoids, the chemical compounds found in cannabis. In 2024, the legal landscape surrounding these substances underwent significant changes, allowing access to certain cannabinoids whilst maintaining strict regulations to ensure public safety. This article aims to provide a comprehensive overview of legal cannabinoids in France in 2024, focusing on those authorised for consumption and use. Here are 10 legal cannabinoids in 2024!
1. CBD (cannabidiol)
CBD is undoubtedly the best-known and most widely accepted cannabinoid in France. Unlike THC, CBD has no psychoactive effects, meaning it does not produce a ‘high’. In 2024, CBD is legal in France, provided it is extracted from cannabis plants containing less than 0.2% THC. CBD is available in several forms, including oils, creams, capsules and dried flowers for vaping or infusions.
2. CBG (cannabigerol)
CBG, less well known than CBD, is another cannabinoid that is legal in France. It is often referred to as the ‘mother cannabinoid’ because other cannabinoids are synthesised from its acid form. CBG is being studied for its potential health benefits, particularly its anti-inflammatory and analgesic properties. Like CBD, CBG must be extracted from cannabis plants containing less than 0.2% THC to be considered legal.
3. CBN (cannabinol)
CBN is a breakdown product of THC and is present in small quantities in the cannabis plant. In France, CBN is legal under certain conditions, notably that it must not be synthesised from THC but extracted naturally. Although less researched than CBD or CBG, CBN is attracting interest for its potential effects on sleep and relaxation.
4. CBDV (cannabidivarine)
CBDV is another cannabinoid that is legal in France, similar to CBD but with a slightly different molecular structure. It is being studied for its potential effects on neurological disorders, particularly epilepsy. Like the other cannabinoids mentioned, CBDV must be extracted from plants containing less than 0.2% THC to be considered legal.
5. THCV (tetrahydrocannabivarin)
THCV is a close relative of THC but has distinct, non-psychoactive effects, depending on the dose. In France, THCV is legal under certain conditions, notably that it must not exceed the regulatory THC threshold in the finished product. THCV is sought after for its potential effects on appetite, metabolism, and as a mood regulator.
6. THCP (tetrahydrocannabiphorol)
THCP is a recently discovered cannabinoid and is considered to have a significantly higher affinity for CB1 receptors compared to other cannabinoids, suggesting potentially stronger effects. Its legality in France depends on its THC concentration, which must remain below the legal limit. Research into THCP is still in its early stages, and its use is strictly regulated.
7. CBDP (cannabidiphorol)
CBDP is another newly identified cannabinoid, similar to CBD but with a longer side chain. Although research is still limited, CBDP may offer benefits similar to those of CBD, without psychoactive effects. Its legal status in France follows that of CBD, requiring a THC content below the legal threshold.
8. THCJD (tetrahydrocannabijol)
THCJD is a lesser-known cannabinoid and is one of the many minor compounds found in cannabis. As with other cannabinoids, its legality in France depends on the THC concentration in the finished product. Information and research on THCJD are limited, and its use is subject to the same strict regulations as other potent cannabinoids.
9. H4CBD (hydrogenated cannabidiol)
H4CBD is a synthetic cannabinoid, a hydrogenated version of CBD, meaning it has been chemically modified to increase its stability and potentially its efficacy. In 2024, the legality of H4CBD in France depends on its compliance with current regulations regarding synthetic cannabinoids, including the absence of THC. Research into H4CBD is promising, particularly regarding its potential anti-inflammatory and anxiolytic effects.
10. Magic Sauce (enhanced THCP)
Magic Sauce represents a significant breakthrough in the field of cannabinoids, being an enhanced version of THCP. In France, this specific formulation is legal, provided it complies with strict regulatory standards regarding THC concentration, not exceeding the legal threshold.
Advice for consumers
- Caution with new cannabinoids : Cannabinoids such as THCP and CBDP are relatively new and have been the subject of limited research. Please exercise caution and ensure you are well-informed before using them.
- Medical consultation : For those considering using cannabinoids for therapeutic purposes, it is essential to consult a qualified healthcare professional. Cannabinoids are not medicines but wellness supplements.
- Responsible purchasing: Always purchase cannabinoids from reliable and legal sources in France, checking for certifications and laboratory analyses.
French legislation on cannabinoids continues to evolve, reflecting scientific advances and public health considerations. Stay up to date with the latest information to ensure your use of cannabinoids remains safe, legal and informed.
See also:
Two new cannabinoids already making waves: THCV & H4CBD
